Clinical trials
Melanoma trials in the United States with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 3 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 5 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 4 |
| 2021 | 8 |
| 2022 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 65 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| CancerVax Corporation | 3 |
| California Pacific Medical Center Research Institute | 2 |
| Genta Incorporated | 2 |
| Genzyme, a Sanofi Company | 2 |
| Herbert Irving Comprehensive Cancer Center | 2 |
| Massachusetts General Hospital | 2 |
| NGM Biopharmaceuticals, Inc | 2 |
| Provectus Biopharmaceuticals, Inc. | 2 |
| San Diego Pacific Oncology & Hematology Associates | 2 |
| Advanced Life Sciences, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Melanoma | 65 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Breast Neoplasms | 8 |
| Neoplasm Metastasis | 8 |
| Pancreatic Neoplasms | 7 |
| Colorectal Neoplasms | 6 |
| Ovarian Neoplasms | 6 |
| Stomach Neoplasms | 6 |
| Carcinoma, Renal Cell | 5 |
| Esophageal Neoplasms | 5 |
Trials
Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.